Ferhan Saleem, Christopher J Ryerson, Nandini Sarma, Kerri Johannson, Veronica Marcoux, Jolene Fisher, Deborah Assayag, Helene Manganas, Nasreen Khalil, Julie Morisset, Ian N Glaspole, Nicole Goh, Justin M Oldham, Gerard Cox, Charlene Fell, Andrea S Gershon, Andrew Halayko, Nathan Hambly, Stacey D Lok, Shane Shapera, Teresa To, Pearce G Wilcox, Alyson W Wong, Martin Kolb, Yet H Khor
RATIONALE: Hypoxemia in fibrotic interstitial lung disease (ILD) indicates disease progression and is of prognostic significance. The onset of hypoxemia signifies disease progression and predicts mortality in fibrotic interstitial lung diseases (ILD). Accurately predicting new-onset exertional and resting hypoxemia prompts appropriate patient discussion and timely consideration of home oxygen. OBJECTIVE: We derived and externally validated a risk prediction tool for both new-onset exertional and resting hypoxemia...
September 7, 2023: Annals of the American Thoracic Society